•
8 min read
CAR-T Cell Therapy in India: Affordable Blood Cancer Treatment for International Patients 2026
India's homegrown CAR-T therapy NexCAR19 costs $30,000 versus $400,000+ in the USA. Learn about eligibility, the treatment process, and centres offering CAR-T for leukaemia and lymphoma in India.
CAR-T TherapyBlood CancerLeukaemia
Priya Sharma
Oncology & Cancer Care Writer
